Walder Wyss advised the funds managed by OrbiMed Advisors LLC on secure financing to vVARDIS group, a Swiss developer and manufacturer of dental products. The context Founded by Dr. Haley Abivardi and Dr. Goly Abivardi,
Tags :OrbiMed
BGPartner has advised OrbiMed and Novo Holdings on Swiss legal matters related to the USD 200 million Series A financing of Windward Bio Group, a Swiss-based clinical-stage drug development company, advised by Homburger. The financing round
Swiss biotech company Alentis Therapeutics has successfully closed a $181.4 million oversubscribed Series D financing round, supported by a syndicate of top-tier biotech investors. The financing will support the company to develop a deep pipeline of
